PharmaVOICE magazine, reaching more than 17,500 life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE, and its supporting VIEW publications, provide readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Additionally, PharmaVOICEMarketplace.com provides a comprehensive directory of products, services, and solutions for the life-sciences industry.

To Raise Your VOICE, contact feedback@pharmavoice.com.

We all know that even before the current economic difficulties the pharma and broader healthcare industry was facing challenges like never before. The dearth of new blockbuster medicines, increased cost containment and spiralling research costs mean that as an industry we need to be more innovative and more nimble. As a result, I believe the industry has rallied together and there is a wealth of debate on new business models and approaches that will drive the two unique aims of our industry - improvement in the quality / length of people's lives and commercial sustainability. Currently, this debate is typically held on conferences or within fairly closed groups (e.g. local country / business function groups). However, there is no well-used universal site for the industry online where everyone can share constructive ideas and opinions, or just ask others for advice. That is where the vision for pharmaphorum emerged from - this is your site and I hope it will become a hub for constructive industry debate and sharing of ideas.

www.pharmaphorum.com

Pharmaceutical Executive Global Digest is the leading strategy based business management publication for senior executives, corporate strategists and sales & marketing leaders in the global pharmaceutical industry. Pharmaceutical Executive Global Digest reaches over 68,000 readers on a bi-weekly basis in an easy to read digital format.

Tackling strategic business and marketing issues, Pharmaceutical Executive Global Digest provides complete high-quality analysis, opinion and industry news on critical trends and developments; sales and marketing strategies; corporate policy, management and branding; research and development; legislation; finance; new technologies.

Readers of Pharmaceutical Executive Global Digest include top C-suite pharmaceutical executives plus marketeers, contract organisations and management consultants, all with direct links to the pharmaceutical industry.

FirstWord Publishing is a leader in the supply of industry intelligence solutions for the pharmaceutical industry. Its flagship news service is sent to over 100,000 pharmaceutical professionals on a daily basis and is rated by subscribers as the leading source of news for the pharma industry.

20/20 Pharma, published by IMI, is a magazine which presents insightful analysis of current events, developments, and trends in the pharmaceutical world.

Innovation cannot spur change without the appropriate venues for collaboration and discussion - this space is where 20/20 Pharma resides.

With an array of new techniques surfacing in R&D, and as companies work to overcome the challenges of efficient drug development in a highly regulatory environment, the U.S. pharma industry is moving forward with the aid of top vendors and open lines of communication.

20/20 Pharma facilitates those conversations, by providing a platform of communication where industry leaders can exchange opinions, ideas, insights and experiences - from savvy business and marketing strategies to tactics for better clinical trials and more efficient drug discovery.

The publication has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision makers to have the means to procure and plan implementation strategies based on the topics covered.

Positioned to be an authoritative resource within top pharma companies as well as small, specialty and biotech businesses, 20/20 Pharma is geared to a highly targeted and responsive audience, bridging the gap between the industries top issues and the solutions top-tier vendors can provide.

http://2020pharma.com

Farmavita.Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers

Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.

Our business concept is very simple:

1. All offer/demand at Farmavita.Net is published anonymously
2. There is no charge for publishing or input into Farmavita.Net database
3. Only in case when we find suitable business partnership match we will ask for non-exclusive agency agreement, with specific customer protection
4. We charge only supplier
5. We do not ask for consulting or retainer fees
6. We will ask for commission related to royalties/down-payment, and related to supply of goods

For the carefully selected innovative projects/products, we are can provide venture capital resources and integral project management support.

PharmaTimes Magazine: independent reporting, for the independent thinker

PharmaTimes Magazine isn't just for pharma... in line with the growing recognition that closer working between pharma and the NHS is key to 21st century healthcare, PharmaTimes has expanded its focus, from April 2011, to provide a platform for both sides to hear about the latest news, thoughts, and initiatives in this important area.

Our portfolio also includes: www.pharmatimes.com; three free online news services delivered by email including World, UK and Clinical news; PharmaTimes Directors Club, where thought-leaders meet to discuss the issues of the day; and a unique series of competitions including marketing, clinical and sales that recognise, reward and celebrate excellence.

www.pharmatimes.com

More information coming soon...

More information coming soon...

More information coming soon...

More information coming soon...

More information coming soon...

More information coming soon...

More information coming soon...

More information coming soon...

More information coming soon...

More information coming soon...

StayinFront is a global provider of the world's most innovative relationship management solutions. From on-demand and on-premise CRM to mobile CRM access in the field using Android™, iPhones and iPads, its ground-breaking software offers rich functionality, fast deployment and easy-to-use tools that increase sales force effectiveness. StayinFront has been selected as a strategic partner by many of the world's top life sciences, consumer goods and business-to-business companies, improving efficiencies in over 65 countries and more than 25 languages.

StayinFront continues its heritage of developing, delivering and supporting the world's best CRM solutions. It has everything that a sales team needs to sell more and manage better. We have been commented by Gartner to be the 'Best in Breed CRM solution' in the 2011 report.

The Business Year (TBY) is a leading provider of business investment consultancy services and publisher of yearly information resources on national economies and business environments. The Business Year provides accurate, timely and country specific economic and business data.

We meet with the country's economic decision makers and business leaders to provide targeted information, in-depth analysis and strategic advice to the global business community on economic trends and investment opportunities. Written by experts based in country for months at a time who work closely with local business leaders and key stakeholders, our books provide in-depth and authoritative analysis of the business community in the countries that we survey.

The Business Year assesses trends and developments in all major economic sectors of the country, including real estate, telecoms, construction, finance, banking, tourism, industry, and energy and is one of the most comprehensive annual economic publications available internationally on the countries we cover.